During the past decade, Christchurch Heart Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Christchurch Heart Institute" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Christchurch Heart Institute" are "Heart Failure" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Heart Diseases" (1 trials) and "Iron-deficiency" (1 trials). Many other conditions were trialed in "Christchurch Heart Institute" in a lesser frequency.

Most popular intervention types in "Christchurch Heart Institute" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ferric Carboxymaltose" (1 trials), "Finerenone (BAY94-8862)" (1 trials), "RAS-antagonist and beta-blocker none or at stable dose" (1 trials) and "RAS-antagonist and beta-blocker up-to maximal dosages" (1 trials). Other intervention names were less common.

The vast majority of trials in "Christchurch Heart Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Christchurch Heart Institute". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Christchurch Heart Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Christchurch Heart Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".